uz
Feedback
Drug & Poison Information Channel

Drug & Poison Information Channel

Kanalga Telegram’da o‘tish

It provides up to date, evidenced based, concised drug information to all health care professionals. Supervised by: Ph. Amal Al-Najjar. To communicate,participate and questions: @Amal_alNajjar.

Ko'proq ko'rsatish
Mamlakat belgilanmaganTibbiyot10 247
1 962
Obunachilar
-124 soatlar
-47 kunlar
-1230 kunlar

Ma'lumot yuklanmoqda...

Taglar buluti
Ma'lumot yo'q
Muammo bormi? Iltimos, sahifani yangilang yoki bizning qo'llab-quvvatlash boshqaruvchimizga murojaat qiling>.
Kirish va chiqish esdaliklari
---
---
---
---
---
---
Obunachilarni jalb qilish
Iyun '26
Iyun '26
+1
0 kanalda
May '26
+4
0 kanalda
Get PRO
Aprel '26
+4
0 kanalda
Get PRO
Mart '260
0 kanalda
Get PRO
Fevral '26
+3
0 kanalda
Get PRO
Yanvar '26
+6
0 kanalda
Get PRO
Dekabr '25
+2
0 kanalda
Get PRO
Noyabr '25
+3
0 kanalda
Get PRO
Oktabr '25
+6
0 kanalda
Get PRO
Sentabr '25
+3
0 kanalda
Get PRO
Avgust '25
+4
0 kanalda
Get PRO
Iyul '25
+5
0 kanalda
Get PRO
Iyun '25
+7
0 kanalda
Get PRO
May '25
+5
0 kanalda
Get PRO
Aprel '250
0 kanalda
Get PRO
Mart '25
+2
0 kanalda
Get PRO
Fevral '25
+5
0 kanalda
Get PRO
Yanvar '25
+8
0 kanalda
Get PRO
Dekabr '24
+5
0 kanalda
Get PRO
Noyabr '24
+2
0 kanalda
Get PRO
Oktabr '24
+2
0 kanalda
Get PRO
Sentabr '24
+11
0 kanalda
Get PRO
Avgust '24
+18
0 kanalda
Get PRO
Iyul '24
+4
0 kanalda
Get PRO
Iyun '24
+1
0 kanalda
Get PRO
May '24
+9
0 kanalda
Get PRO
Aprel '24
+8
0 kanalda
Get PRO
Mart '24
+6
0 kanalda
Get PRO
Fevral '24
+8
0 kanalda
Get PRO
Yanvar '24
+15
1 kanalda
Get PRO
Dekabr '23
+8
0 kanalda
Get PRO
Noyabr '23
+4
0 kanalda
Get PRO
Oktabr '23
+7
0 kanalda
Get PRO
Sentabr '23
+10
0 kanalda
Get PRO
Avgust '23
+5
0 kanalda
Get PRO
Iyul '23
+6
0 kanalda
Get PRO
Iyun '23
+13
0 kanalda
Get PRO
May '23
+20
0 kanalda
Get PRO
Aprel '23
+8
0 kanalda
Get PRO
Mart '23
+8
0 kanalda
Get PRO
Fevral '23
+7
0 kanalda
Get PRO
Yanvar '23
+18
0 kanalda
Get PRO
Dekabr '22
+16
0 kanalda
Get PRO
Noyabr '22
+52
0 kanalda
Get PRO
Oktabr '22
+24
0 kanalda
Get PRO
Sentabr '22
+20
0 kanalda
Get PRO
Avgust '22
+12
0 kanalda
Get PRO
Iyul '22
+13
0 kanalda
Get PRO
Iyun '22
+16
0 kanalda
Get PRO
May '22
+61
0 kanalda
Get PRO
Aprel '22
+26
0 kanalda
Get PRO
Mart '22
+14
0 kanalda
Get PRO
Fevral '22
+27
0 kanalda
Get PRO
Yanvar '22
+14
0 kanalda
Get PRO
Dekabr '21
+16
0 kanalda
Get PRO
Noyabr '21
+17
0 kanalda
Get PRO
Oktabr '21
+25
0 kanalda
Get PRO
Sentabr '21
+31
0 kanalda
Get PRO
Avgust '21
+19
0 kanalda
Get PRO
Iyul '21
+25
0 kanalda
Get PRO
Iyun '21
+65
0 kanalda
Get PRO
May '21
+14
0 kanalda
Get PRO
Aprel '21
+21
0 kanalda
Get PRO
Mart '21
+44
0 kanalda
Get PRO
Fevral '21
+30
0 kanalda
Get PRO
Yanvar '21
+41
0 kanalda
Get PRO
Dekabr '20
+2 219
0 kanalda
Sana
Obunachilarni jalb qilish
Esdaliklar
Kanallar
21 Iyun0
20 Iyun0
19 Iyun0
18 Iyun0
17 Iyun0
16 Iyun0
15 Iyun0
14 Iyun0
13 Iyun0
12 Iyun0
11 Iyun0
10 Iyun0
09 Iyun0
08 Iyun0
07 Iyun+1
06 Iyun0
05 Iyun0
04 Iyun0
03 Iyun0
02 Iyun0
01 Iyun0
Kanal postlari
كيف نفهم أرقام الـ (Hazard Ratio) بشكل عام؟ إذا كان الـ HR يساوي 1: العلاجان متطابقان تماماً، ولا يوجد أي فرق في الخطورة بين المجموعتين. إذا كان الـ HR أقل من 1 (مثل 0.58): العلاج الجديد أفضل، لأنه يقلل من احتمالية حدوث الشيء السيء (تفاقم المرض) ويطيل فترة استقرار المريض. إذا كان الـ HR أكبر من 1 (مثلاً 1.5): العلاج الجديد أسوأ، لأنه يزيد من خطر تفاقم المرض بنسبة 50%.

2
*Dear Doctor,* I would highly appreciate your participation in our research study titled: *“Effectiveness and Diagnostic Reliability of Tele-dermatology in Primary Care among Family Physicians in Riyadh, Saudi Arabia.”* The survey takes approximately 3 minutes to complete and aims to assess Family physicians’ experiences with virtual dermatology consultations. Participation is voluntary, and all responses are anonymous and confidential. *survey link:* https://forms.gle/PJVigwYeqcdas1Bx6 *Thank you for your valuable time and contribution.*
191
3
https://share.google/DDVcRiNiYAfzsMjy7
0
4
Matn yo'q...
0
5
For more than 60 years, Metformin has been prescribed to hundreds of millions of people with Type 2 Diabetes. While clinicians knew it was effective, the exact mechanism behind its action remained only partially understood. Researchers at Baylor College of Medicine have now uncovered a crucial aspect of this mystery. Their findings, published in Science Advances, suggest that metformin works directly through the brain, revealing a previously unidentified mechanism. The study focuses on a protein called Rap1 located in the Ventromedial Hypothalamus, a key control center for whole-body metabolism. When metformin reaches the VMH, it switches off Rap1, which activates a group of neurons known as SF1 neurons. These neurons then signal the body to reduce blood glucose levels. In experiments, mice genetically engineered without Rap1 in this brain region showed a striking result: metformin stopped working entirely, even when the mice were on a high-fat diet. Interestingly, other diabetes treatments, such as insulin and GLP-1 receptor agonists, continued to function normally, suggesting that this brain pathway is unique to metformin. Another remarkable finding was the brain’s extreme sensitivity to the drug. While the liver and intestines require relatively high drug concentrations to respond, the brain reacted to doses thousands of times lower than typical oral doses. These insights reshape decades of understanding. Metformin may not simply act through the liver or gut as traditionally believed, it has likely been influencing the brain’s metabolic control systems all along. Researchers are now exploring whether this Rap1 brain pathway could also explain metformin’s other reported benefits, including potential effects on brain aging and longevity. Human studies are still required to confirm these mechanisms, but the discovery opens the door to more precise and targeted diabetes therapies in the future. 📄 Reference: Lin et al. (2025). Low-dose metformin requires brain Rap1 for its antidiabetic action. Science Advances.
0